Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SOS1 | Q07889 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6893360 | 0.88 | KMT2A (0.41) | KMT2ATDP1SOS1ALDH1A1CA1 | |
| SCHEMBL67606 | 0.82 | SOS1 (0.50) | KMT2ASOS1CA2PTGS2PTGS1 | |
| SCHEMBL10571424 | 0.82 | ALDH1A1 (0.39) | KMT2ATDP1SOS1ALDH1A1HSD17B10 | |
| SCHEMBL1940923 | 0.82 | PTGS2 (0.42) | TDP1SOS1ALDH1A1HSD17B10CA1 | |
| SCHEMBL5839980 | 0.80 | CA1 (0.41) | TDP1SOS1ALDH1A1HSD17B10CA1 | |
| SCHEMBL2780594 | 0.80 | CA1 (0.47) | KMT2ATDP1SOS1ALDH1A1HSD17B10 | |
| SCHEMBL733946 | 0.80 | TSHR (0.51) | KMT2AALDH1A1HSD17B10PTGS2PTGS1 | |
| SCHEMBL30161644 | 0.80 | TSHR (0.51) | KMT2AALDH1A1HSD17B10PTGS2PTGS1 | |
| SCHEMBL320225 | 0.80 | CA2 (0.40) | KMT2ATDP1SOS1ALDH1A1HSD17B10 | |
| SCHEMBL2778156 | 0.80 | CA1 (0.68) | KMT2ATDP1ALDH1A1HSD17B10CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 749 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| CN-119565410-A | Seawater desalination reverse osmosis membrane, preparation method and application | 湖南澳维膜科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-117624140-A | CXCR4 antagonists, methods of making and uses thereof | 杭州师范大学 | 2024-03-01 | — | — | CN | claimed |
| US-20240011009-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2024-01-11 | — | — | US | claimed |
| US-20230220589-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2023-07-13 | — | — | US | claimed |
| EP-4127157-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2023-02-08 | — | — | EP | claimed |
| WO-2022072560-A1 | POLYPEPTIDE TERMINAL BINDERS AND USES THEREOF | Encodia, Inc. (US) | 2022-04-07 | — | — | WO | claimed |
| WO-2021194908-A1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | Encodia, Inc. (US) | 2021-09-30 | — | — | WO | claimed |
| EP-4743446-A1 | NITRO-CONTAINING COMPOUNDS THAT KILL MYCOBACTERIA | Board of Trustees of Michigan State University (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12630529-B2 | GCN2 modulator compounds | Alesta Therapeutics BV (NL) | 2026-05-19 | — | — | US | disclosed |
| US-12570613-B2 | Imidazoquinoline or benzoindazolone compound and intermediate for preparing same | LMITO THERAPEUTICS INC. (KR) | 2026-03-10 | — | — | US | disclosed |
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | disclosed |
| CN-120640936-A | Perovskite solar cell modified by 3, 4-difluorobenzenesulfonyl chloride | 西南石油大学 | 2025-09-12 | — | — | CN | disclosed |
| CN-120640936-A | Perovskite solar cell modified by 3, 4-difluorobenzenesulfonyl chloride | 西南石油大学 | 2025-09-12 | — | — | CN | disclosed |
| US-5849926-A | Pyrazole derivatives and herbicides containing the same | IDEMITSU KOSAN CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5756759-A | HERBICIDES | IDEMITSU KOSAN CO., LTD. (JP) | 1998-05-26 | — | — | US | disclosed |
| EP-0728756-A1 | PYRAZOLE DERIVATIVES AND HERBICIDE CONTAINING THE SAME | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1996-08-28 | — | — | EP | disclosed |
| WO-1995032500-A1 | SULFONAMIDES USEFUL AS LUBRICANTS IN MAGNETIC RECORDING MEDIA | THE DOW CHEMICAL COMPANY (US) | 1995-11-30 | — | — | WO | disclosed |
| US-5212301-A | SUBSTITUTED FLUOROBENZENES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-05-18 | — | — | US | disclosed |
| EP-0512715-A2 | Verfahren zur Herstellung einer in 3-Stellung fluorierten aromatischen Verbindung | ZENECA LIMITED (GB) | 1992-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630529-B2 | GCN2 modulator compounds | NR3C1, GCN1, EIF2AK4 | KMT2A 3057/4885TDP1 3878/4885SOS1 2617/4885 |
| US-12570613-B2 | Imidazoquinoline or benzoindazolone compound and intermediate for preparing same | NQO1, CBR1, NFE2L2 | KMT2A 3455/4885TDP1 2395/4885SOS1 1911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.